To further demonstrate that SHMT2 may promote the occurrence and development of GC and affect the prognosis of patients via certain pathways, we searched the relevant signalling pathways involved in the SHMT2 by Assistant for Clinical Bioinformatics. The gene discussed is SHMT2; the disease is gastric cancer.